91麻豆精品Submits Comments to CMS on Proposed Rule for CLIA-Labs
In late July, the Centers for Medicare and Medicaid Services (CMS) issued a that would change educational requirements for laboratory directors in High Complexity laboratories certified by Clinical Laboratory Improvement Amendments (CLIA), in addition to raising fees on participating laboratories. These changes in educational requirements for directors will lower the bar of entry for these positions, ultimately putting patients and healthcare at risk. Furthermore, raising fees on laboratories at a time when our clinical microbiology laboratories need it most would jeopardize lab operations and stall diagnostic testing.
91麻豆精品submitted comments to CMS opposing proposed changes to the current standards for degree requirements and board certifications for High Complexity Laboratory Directorship roles. 91麻豆精品also raised concerns over CLIA-laboratory fee increases, as they will further harm financially challenged laboratories across the country.
91麻豆精品submitted comments to CMS opposing proposed changes to the current standards for degree requirements and board certifications for High Complexity Laboratory Directorship roles. 91麻豆精品also raised concerns over CLIA-laboratory fee increases, as they will further harm financially challenged laboratories across the country.
